In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy : Additional Considerations'
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Kidney medicine - 4(2022), 8 vom: 07. Aug., Seite 100503 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fernandes, Guillaume [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 05.09.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.xkme.2022.100503 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342863746 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342863746 | ||
| 003 | DE-627 | ||
| 005 | 20231226015108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xkme.2022.100503 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342863746 | ||
| 035 | |a (NLM)35765465 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fernandes, Guillaume |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy |b Additional Considerations' |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Devresse, Arnaud |e verfasserin |4 aut | |
| 700 | 1 | |a Scohy, Anais |e verfasserin |4 aut | |
| 700 | 1 | |a De Greef, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Yombi, Jean Cyr |e verfasserin |4 aut | |
| 700 | 1 | |a Belkhir, Leila |e verfasserin |4 aut | |
| 700 | 1 | |a Darius, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Mourad, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Buemi, Antoine |e verfasserin |4 aut | |
| 700 | 1 | |a Kabamba, Benoit |e verfasserin |4 aut | |
| 700 | 1 | |a Goffin, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Kanaan, Nada |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney medicine |d 2019 |g 4(2022), 8 vom: 07. Aug., Seite 100503 |w (DE-627)NLM303572787 |x 2590-0595 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2022 |g number:8 |g day:07 |g month:08 |g pages:100503 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xkme.2022.100503 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2022 |e 8 |b 07 |c 08 |h 100503 | ||